arrow
P

Paulina Haight

James Cancer Hospital and Solove Research Institute
H指数:9
被引数:288

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MLH1 promoter hypermethylation and associations with survival outcomes: A real-world endometrial cancer molecularly targeted therapy consortium cohort study

MLH1启动子高甲基化及其与生存结局的关联:一项真实世界子宫内膜癌分子靶向治疗联盟队列研究

2026-07-010
PRE
PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy

PRO-PLATINUM:一项随机、双盲、安慰剂对照研究,旨在探究益生菌干预对接受铂类化疗的卵巢癌患者肠道和阴道微生物组的影响

2026-06-010
OA
Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability

子宫内膜癌中lenvatinib与pembrolizumab联合应用的评估;一项关于实践模式、有效性和耐受性的真实世界多机构回顾。

2025-08-140
PRE
Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study

无铂间期及对复发性子宫内膜癌患者铂类再治疗或lenvatinib/pembrolizumab的应答:一项真实世界子宫内膜癌分子靶向治疗联盟队列研究

2025-03-010
PRE